Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE
January 14, 2021 08:00 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Topiramate Oral Solution
December 17, 2020 08:00 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
Eton Pharmaceuticals Announces Availability of Orphan Drug ALKINDI® SPRINKLE (hydrocortisone) in the United States
November 24, 2020 09:00 ET
|
Eton Pharmaceuticals
ALKINDI® SPRINKLE is now exclusively available through AnovoRx Specialty Pharmacy. To support patient access to ALKINDI® SPRINKLE, Eton has established the Eton Cares Program®. DEER PARK, Ill., Nov....
Eton Pharmaceuticals Announces Third Quarter 2020 Financial Results
November 12, 2020 16:05 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
Eton Pharmaceuticals to Report Third Quarter Financial Results on Thursday, November 12, 2020
November 04, 2020 16:05 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
Eton Pharmaceuticals Announces Closing of Public Offering
October 16, 2020 16:05 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Oct. 16, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Zonisamide Oral Suspension
October 15, 2020 08:30 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
Eton Pharmaceuticals Prices Underwritten Public Offering of Common Stock
October 14, 2020 08:30 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
Eton Pharmaceuticals Announces Proposed Public Offering of Common Stock
October 13, 2020 16:01 ET
|
Eton Pharmaceuticals
DEER PARK, Ill. , Oct. 13, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Orphan Drug Dehydrated Alcohol Injection
October 08, 2020 08:00 ET
|
Eton Pharmaceuticals
- Application Assigned a PDUFA Date of May 27, 2021 - Dehydrated Alcohol Injection Market Estimated to be Greater Than $100 Million Annually - Application has Received Orphan Drug Designation for...